Last updated on 10 Sept 2024
Owner Info
Apellis Pharmaceuticals, Inc.
Attn: Legal Department,
100 Fifth Avenue, Third Floor, UNITED STATES OF AMERICA
Serial Number
2461709 filed on 12 Apr 2024
Correspondent
John V. Hobgood, Esquire Wilmer Cutler Pickering Hale and Dorr LLP
60 State Street,
Boston MA 02109,
UNITED STATES OF AMERICA
2461709
NA
NA
WORD
12 Oct 2023
US
Status Date | Action Taken |
---|---|
10th Sept 2024 | International Registration in Australia Protected correspondence sent |
9th Sept 2024 | IP Right Registration Published |
9th Sept 2024 | Status change to Registered/Protected |
3rd Jul 2024 | Application Accepted correspondence sent |
2th Jul 2024 | IP Right has been Examined |
2th Jul 2024 | IP Right Acceptance Published |
2th Jul 2024 | Status change to Accepted |
2th Jul 2024 | Awaiting examination |
2th Jul 2024 | Examination expedited |
2th Jul 2024 | Word and image indexing completed |